AIMI: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Loss (gain) on sale of marketable investments	-	18
Net loss	-9,783	-6,499
Depreciation of property and equipment	28	19
Abandonment and expiration of patents and trademark rights	697	615
Amortization of patent, trademark rights	139	94
Non-cash lease expense	-140	-81
Equity-based compensation	60	60
Gain on sale of marketable securities	17	-
Amortization of financial obligation	252	183
Change in fair value of warrants	-670	-
Loss on issuance of warrants	-3,977	0
Non-cash gain on settlement of liability	-3,041	-
Prepaid expenses and other current assets	-33	-9
Lease liability	-134	-78
Funds receivable from new jersey net operating loss	-	0
Other assets	-750	-761
Accounts payable	-1,656	914
Accrued expenses	254	-33
Net cash used in operating activities	-8,971	-3,892
Proceeds from sale of marketable securities	2,322	2,026
Purchase of marketable securities	91	91
(purchase) abandonment of patent and trademark rights	283	283
Net cash provided by investing activities	1,948	1,652
Proceeds from issuance of common stock and warrants	7,314	-
Proceeds from sale of stock, net of issuance costs	367	765
Proceeds from note payable, net of issuance costs	250	250
Repayment of debt with cash	660	-
Proceeds from issuance of equity warrants	-	0
Proceeds from equity line of credit	398	-
Net cash provided by financing activities	7,669	1,015
Net increase (decrease) in cash and cash equivalents	646	-1,225
Cash and cash equivalents at beginning of period	1,701	-
Cash and cash equivalents at end of period	2,347	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

AIMI: the cashflow